TY - JOUR
T1 - Artificial intelligence
T2 - improving the efficiency of cardiovascular imaging
AU - Lin, Andrew
AU - Kolossváry, Márton
AU - Išgum, Ivana
AU - Maurovich-Horvat, Pál
AU - Slomka, Piotr J.
AU - Dey, Damini
N1 - Funding Information:
This paper was funded in part by a grant from the National Heart, Lung, and Blood Institute [1R01HL133616].
Publisher Copyright:
© 2020, © 2020 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2020/6/2
Y1 - 2020/6/2
N2 - Introduction: Artificial intelligence (AI) describes the use of computational techniques to mimic human intelligence. In healthcare, this typically involves large medical datasets being used to predict a diagnosis, identify new disease genotypes or phenotypes, or guide treatment strategies. Noninvasive imaging remains a cornerstone for the diagnosis, risk stratification, and management of patients with cardiovascular disease. AI can facilitate every stage of the imaging process, from acquisition and reconstruction, to segmentation, measurement, interpretation, and subsequent clinical pathways. Areas covered: In this paper, we review state-of-the-art AI techniques and their current applications in cardiac imaging, and discuss the future role of AI as a precision medicine tool. Expert opinion: Cardiovascular medicine is primed for scalable AI applications which can interpret vast amounts of clinical and imaging data in greater depth than ever before. AI-augmented medical systems have the potential to improve workflow and provide reproducible and objective quantitative results which can inform clinical decisions. In the foreseeable future, AI may work in the background of cardiac image analysis software and routine clinical reporting, automatically collecting data and enabling real-time diagnosis and risk stratification.
AB - Introduction: Artificial intelligence (AI) describes the use of computational techniques to mimic human intelligence. In healthcare, this typically involves large medical datasets being used to predict a diagnosis, identify new disease genotypes or phenotypes, or guide treatment strategies. Noninvasive imaging remains a cornerstone for the diagnosis, risk stratification, and management of patients with cardiovascular disease. AI can facilitate every stage of the imaging process, from acquisition and reconstruction, to segmentation, measurement, interpretation, and subsequent clinical pathways. Areas covered: In this paper, we review state-of-the-art AI techniques and their current applications in cardiac imaging, and discuss the future role of AI as a precision medicine tool. Expert opinion: Cardiovascular medicine is primed for scalable AI applications which can interpret vast amounts of clinical and imaging data in greater depth than ever before. AI-augmented medical systems have the potential to improve workflow and provide reproducible and objective quantitative results which can inform clinical decisions. In the foreseeable future, AI may work in the background of cardiac image analysis software and routine clinical reporting, automatically collecting data and enabling real-time diagnosis and risk stratification.
KW - Artificial intelligence
KW - cardiovascular imaging
KW - deep learning
KW - machine learning
KW - precision medicine
KW - risk stratification
UR - https://www.scopus.com/pages/publications/85086792898
U2 - 10.1080/17434440.2020.1777855
DO - 10.1080/17434440.2020.1777855
M3 - Review Article
C2 - 32510252
AN - SCOPUS:85086792898
SN - 1743-4440
VL - 17
SP - 565
EP - 577
JO - Expert Review of Medical Devices
JF - Expert Review of Medical Devices
IS - 6
ER -